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A growing number of studies have character-
ized a variety of paired activating and inhibitory 
receptors (Ravetch and Lanier, 2000; Klesney-
Tait et al., 2006; Lanier, 2009). We have pre-
viously  identified  a  leukocyte  mono-Ig–like 
receptor (LMIR) mainly expressed in myeloid 
cells (Kumagai et al., 2003; Izawa et al., 2007; 
Yamanishi  et  al.,  2008).  The  mouse  LMIR 
family  is  also  known  as  the  CMRF-35–like 
molecule/myeloid-associated Ig-like receptor/
dendritic cell–derived Ig-like receptor/CD300 
family (Luo et al., 2001; Chung et al., 2003; 
Yotsumoto et al., 2003). LMIR1 and LMIR3 
are immunoreceptor tyrosine-based inhibitory 
motif–containing inhibitory receptors, whereas 
other members are activating receptors that   
associate with immunoreceptor tyrosine-based 
activation  motif–containing  adaptor  proteins 
(Luo et al., 2001; Chung et al., 2003; Kumagai 
et al., 2003; Yotsumoto et al., 2003; Izawa   
et al., 2007; Yamanishi et al., 2008). LMIR5 is 
a DAP12-coupled activating receptor predom-
inantly expressed in myeloid cells (Yamanishi 
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Leukocyte mono-immunoglobulin (Ig)–like receptor 5 (LMIR5)/CD300b is a DAP12-coupled 
activating receptor predominantly expressed in myeloid cells. The ligands for LMIR have not 
been reported. We have identified T cell Ig mucin 1 (TIM1) as a possible ligand for LMIR5 by 
retrovirus-mediated expression cloning. TIM1 interacted only with LMIR5 among the LMIR 
family, whereas LMIR5 interacted with TIM4 as well as TIM1. The Ig-like domain of LMIR5 
bound to TIM1 in the vicinity of the phosphatidylserine (PS)-binding site within the Ig-like 
domain of TIM1. Unlike its binding to TIM1 or TIM4, LMIR5 failed to bind to PS. LMIR5 
binding did not affect TIM1- or TIM4-mediated phagocytosis of apoptotic cells, and stimu-
lation with TIM1 or TIM4 induced LMIR5-mediated activation of mast cells. Notably, LMIR5 
deficiency suppressed TIM1-Fc–induced recruitment of neutrophils in the dorsal air pouch, 
and LMIR5 deficiency attenuated neutrophil accumulation in a model of ischemia/reperfu-
sion injury in the kidneys in which TIM1 expression is up-regulated. In that model, LMIR5 
deficiency resulted in ameliorated tubular necrosis and cast formation in the acute phase. 
Collectively, our results indicate that TIM1 is an endogenous ligand for LMIR5 and that the 
TIM1–LMIR5 interaction plays a physiological role in immune regulation by myeloid cells.
© 2010 Yamanishi et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Ba/F3 cells by using anti-TIM1 antibody (Fig. 1 A, bottom). 
When  TIM1  was  expressed  in  Ba/F3  cells,  LMIR5-Fc 
strongly stained TIM1-transduced Ba/F3 but not parental 
Ba/F3  cells.  In  addition,  LMIR5-Fc–staining  levels  were 
correlated with TIM1 expression at both surface protein and 
mRNA levels (Fig. 1, A and B). Collectively, these results 
indicated that LMIR5-Fc bound to TIM1. In accordance, 
pretreatment of LMIR5-Fc with 10 µg/ml anti-LMIR5   
antibody, but not control antibody, abolished the binding of 
LMIR5-Fc to TIM1-expressing Ba/F3 cells (Fig. 1 C, left). 
Similarly, the preincubation of TIM1-expressing Ba/F3 cells 
with 100 µg/ml anti-TIM1 antibody (222414) suppressed 
this binding (Fig. 1 D, left). The binding of LMIR5-Fc to 
TIM1-expressing Ba/F3 cells was dose-dependently inhib-
ited by anti-LMIR5 or anti-TIM1 antibody (Fig. 1, C and D, 
right). These observations strongly suggested that LMIR5   
interacts directly with TIM1. Then, Fc fusion proteins con-
taining  the  extracellular  domains  of  LMIR1,  2,  3,  and  4 
(LMIR1/2/3/4-Fc) were generated. TIM1-expressing Ba/F3 
cells were bound only by LMIR5-Fc among the LMIR-Fc 
fusion proteins (Fig. 1 E). When Ba/F3 cells transduced with 
Flag-tagged TIM1, 2, 3, and 4 were incubated with LMIR5-Fc,   
LMIR5-Fc bound to those cells transduced with TIM4 as 
well as TIM1 among the TIM family (Fig. 1 F). In support   
of this, coimmunoprecipitation experiments illustrated the 
physical interaction of LMIR5 with both TIM1 and TIM4 
(Fig. 1 G). After generating Fc fusion proteins containing the 
extracellular domains of TIM1 or 4 (TIM1/4-Fc), we incu-
bated LMIR5- or mock-transduced Ba/F3 cells with TIM1-Fc   
or  TIM4-Fc,  which  stained  LMIR5-transduced  Ba/F3   
cells more strongly as compared with parental Ba/F3 cells 
(Fig. S1 C), indicating that TIM1 or TIM4 bound to surface-
expressed LMIR5. On the other hand, the fact that TIM1-Fc 
or TIM4-Fc stained parental Ba/F3 cells at significant levels 
suggested that ligands for TIM1 or TIM4 other than LMIR5 
were expressed in Ba/F3 cells. Our results suggested that 
TIM1 and TIM4 are possible ligands for LMIR5.
The Ig-like domain of LMIR5 binds to that of TIM1  
in the vicinity of the PS-binding site
To determine which region of LMIR5 was required for the 
interaction with TIM1, we generated LMIR5 deletion mu-
tants (LMIR5 del1/2/3/4/5–Fc; Fig. 2, A and B). Notably, 
like LMIR5-Fc, LMIR5 del1/2/3–Fc bound to TIM1- 
expressing Ba/F3 cells, whereas LMIR5 del4/5–Fc lacking 
the C terminus of the Ig-like domains did not bind at all   
(Fig. 2 C). These results suggested that the intact Ig-like domain 
of LMIR5 is indispensable for the LMIR5–TIM1 interaction.
According to recent reports, TIM1 and TIM4 bind to PS 
through the highly conserved binding cleft (FG–CC’ cleft) of 
the Ig-like domains (Kobayashi et al., 2007; Miyanishi et al., 
2007; Santiago et al., 2007a,b; Ichimura et al., 2008). To 
clarify the involvement of this region in LMIR5–TIM1 bind-
ing, we generated the TIM1 mutants W115A/F116A (WF/AA)   
or N117A/D118A (ND/AA), because these mutations in   
the metal ion–dependent ligand-binding site were reported 
et al., 2008). However, the ligands for LMIR remained un-
known. In this study, we identified T cell Ig mucin 1 (TIM1) 
as  a  ligand  for  LMIR5  by  retrovirus-mediated  expression 
cloning (Kitamura et al., 2003).
TIM1–4 are characterized as important regulators of   
immune responses associated with autoimmunity and allergic 
diseases (McIntire et al., 2001; Kuchroo et al., 2003, 2008). 
The TIM molecules are type 1 cell-surface glycoproteins, 
consisting of an N-terminal IgV domain and a mucin do-
main. TIM1/hepatitis A virus cellular receptor 1 (Kaplan   
et al., 1996)/kidney injury molecule–1 (KIM-1; Ichimura   
et al., 1998) is expressed in activated T cells and delivers a 
signal that enhances T cell activation and proliferation (Meyers 
et al., 2005; Umetsu et al., 2005). TIM1 can also interact 
with itself (Santiago et al., 2007b). In addition, a soluble form 
of KIM-1/TIM1 is released by shedding (Bailly et al., 2002). 
On the other hand, TIM4 is expressed in macrophages and 
dendritic cells and is a natural ligand for TIM1 (Meyers et al., 
2005). Interestingly, TIM1 and TIM4 recognize phosphati-
dylserine (PS) and are critical for the efficient clearance of 
apoptotic cells (Kobayashi et al., 2007; Miyanishi et al., 2007; 
Santiago et al., 2007a; Ichimura et al., 2008). Recent reports 
have demonstrated that the narrow cavity built by the CC’ 
and FG loops of the Ig-like domain is a binding site for PS 
(Kobayashi et al., 2007; Santiago et al., 2007a,b). In addition, 
TIM1/KIM-1 expression is strongly induced in the injured 
kidney epithelial cells (Ichimura et al., 1998, 2008; Waanders 
et al., 2010), and confers a phagocytic phenotype on epithe-
lial cells (Ichimura et al., 2008). TIM1 is also a marker for   
renal tubular damage (Waanders et al. 2010).
In the present study, using biological and biochemical 
analysis, we demonstrate that TIM1 and TIM4 are endogenous 
ligands for LMIR5. In addition, we generated LMIR5/ mice 
and delineated the physiological significance of the LMIR5–
TIM1 interaction by using an acute kidney injury model.
RESULTS
Cloning of the ligand for LMIR5
To identify the LMIR5 ligand, we generated an Fc fusion 
protein  containing  the  extracellular  domain  of  LMIR5 
(LMIR5-Fc). Several hematopoietic cell lines were incubated 
with LMIR5-Fc, which stained A20 cells but not Ba/F3 
cells, as determined by flow cytometric analysis, suggesting 
the expression of LMIR5 ligand in A20 cells (Fig. 1 A). To 
identify the surface protein bound by LMIR5-Fc, we used 
retrovirus-mediated expression cloning (Kitamura et al., 
2003). A retrovirus cDNA library constructed from A20 cells 
was transduced via infection to Ba/F3 cells that were not 
stained by LMIR5-Fc (Fig. 1 A). The transfectants stained by 
LMIR5-Fc were sorted and expanded in culture. This cycle 
of sorting and expansion was repeated three times until 
LMIR5-Fc stained most cells (Fig. S1 A). After we obtained 
single-cell clones that were stained with LMIR5-Fc, we   
isolated TIM1 cDNA from most of these clones by PCR   
(Fig. S1 B and not depicted). We confirmed that a cell-surface 
glycoprotein TIM1 was expressed in A20 cells but not in   JEM VOL. 207, July 5, 2010 
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Figure 1.  Specific binding of LMIR5-Fc to TIM1-expressing cells. (A) The indicated cells or TIM1-transduced Ba/F3 cells were stained with LMIR5-Fc 
(top) or with anti-TIM1 antibody (RMT1-4; bottom). (B) Relative gene expression levels of TIM1 were estimated by using real-time PCR. (C) LMIR5-Fc was 
pretreated with the indicated concentrations (left, 10 µg/ml) of anti-LMIR5 antibody or goat IgG. (D) TIM1-transduced Ba/F3 cells were preincubated with 
the indicated concentrations (left, 100 µg/ml) of anti-TIM1 antibody (222414) or rat IgG2b. TIM1-transduced Ba/F3 cells were then stained with LMIR5-Fc. 
The mean fluorescent intensity (MFI) of LMIR5-Fc staining is shown (C and D, right). (E) TIM1-transduced Ba/F3 cells were stained with LMIR1/2/3/4/5-Fc 
(continuous line histograms). Control staining with human IgG1 is shown (shaded histograms). (F) Ba/F3 cells transduced with Flag-tagged TIM1/2/3/4 or 
mock transduced were stained with LMIR5-Fc (top, continuous line histograms) or with anti-Flag antibody (bottom, continuous line histograms). Control 
staining with human (top, shaded histograms) and mouse IgG1 (bottom, shaded histograms) is shown. (G) TIM1 and TIM4 proteins were detected by  
immunoblotting (IB) with anti-Flag antibody in the immunoprecipitates (IP) of lysates derived from Flag-tagged TIM1-, TIM4-, or mock-transduced Ba/F3 
cells incubated with LMIR5-Fc (top) or anti-Flag antibody (bottom). All data are representative of three independent experiments. ND, not detected.
to dampen TIM1–PS binding (Kobayashi et al., 2007; Santiago 
et al., 2007a). Interestingly, these substitutions completely 
abolished the binding of LMIR5-Fc to TIM1-expressing   
Ba/F3 cells (Fig. 2 D). Collectively, these findings indicated 
that LMIR5 bound to TIM1, presumably through the inter-
action of the Ig-like domain of LMIR5 with the structural 1504 TIM1 is an endogenous ligand for LMIR5/CD300b | Yamanishi et al.
but not LMIR5 promoted phagocytosis of the apoptotic 
cells through recognition of PS (Fig. 3 B). Next, we 
asked  if  the  LMIR5–TIM1  interaction  affected  the 
TIM1-mediated phagocytosis of the apoptotic cells.   
As expected, coincubation with anti-TIM1 antibody   
or TIM1-Fc significantly suppressed phagocytosis of   
the apoptotic cells in TIM1-expressing NIH3T3 cells   
(Fig. 3 C). In contrast, coincubation with LMIR5-Fc 
did not inhibit this phagocytosis (Fig. 3 C). Similarly,   
the interaction of LMIR5 with TIM4 did not affect 
TIM4-mediated phagocytosis of the apoptotic cells in peritoneal 
macrophages (Fig. 3, D and E). Collectively, interaction of nei-
ther TIM1 nor TIM4 with LMIR5 affected the phagocytosis of 
apoptotic cells through its recognition of PS, despite the finding 
that LMIR5 bound to TIM1 or TIM4 at close proximity to the 
PS-binding site.
The TIM1–LMIR5 interaction induces LMIR5-mediated 
activation of mast cells
As previously reported (Kitaura et al., 2003; Yamanishi   
et al., 2008), LMIR5-mediated activation of mast cells de-
pended on LMIR5 expression levels (Fig. 4 A, left). Nota-
bly, stimulation with TIM1-Fc, but not human IgG1 as a 
control, induced significant levels of extracellular signal-
regulated kinase (ERK) activation in LMIR5-transduced 
BM-derived mast cells (BMMCs), whereas no detectable 
levels of ERK activation were induced by TIM1-Fc in 
mock-transduced  BMMCs  (Fig.  4  A,  right).  Similarly, 
stimulation with TIM1-Fc or TIM4-Fc induced cytokine 
production of fetal liver–derived mast cells (FLMCs) trans-
duced with LMIR5, but not mock-transduced cells (Fig. 4 B; 
and  Fig.  S3,  A  and  B).  In  addition,  DAP12  deficiency 
completely  dampened  cytokine  production  of  LMIR5-
transduced FLMCs stimulated by TIM1-Fc, but not PMA 
as a control (Fig. 4 B). These results indicated that TIM1-
Fc or TIM4-Fc activated mast cells through interaction 
with  LMIR5,  which  was  dependent  on  the  expression 
levels of LMIR5. As previously reported (Nakae et al., 
2007), we found high expression levels of TIM3 as well as 
domain formed by FG loops of TIM1. Related to this, we 
found different capabilities of anti-TIM1 antibodies to recog-
nize TIM1 epitopes. Anti-TIM1 antibody (222414) detected 
TIM1 WT and the ND/AA mutant but not the WF/AA 
mutant, whereas anti-TIM1 antibody (RMT1-10) detected 
TIM1 WT and the mutants WF/AA and ND/AA (Fig. S2 A). 
Thus, anti-TIM1 antibody (222414) presumably recognizes 
the FG loop structure that is critically maintained by W115/
F116 but not N117/D118, whereas anti-TIM1 (RMT1-10) 
antibody reacts outside this area of TIM1. Then, we com-
pared the inhibitory effect of these antibodies on LMIR5–
TIM1 binding. Unlike anti-TIM1 antibody (RMT1-10) or 
anti-Flag antibody, anti-TIM1 antibody (222414) pretreat-
ment did inhibit LMIR5–TIM1 binding (Fig. S2 B). Collec-
tively, these results suggested that the Ig-like domain of 
LMIR5 interacted with TIM1 in the region formed by the 
FG loop of the Ig-like domain, the structure of which was 
similar or close to the FG–CC’ cleft bound by PS, and that it 
was recognized by anti-TIM1 antibody (222414).
LMIR5 neither binds to PS nor affects TIM1-  
or TIM4-mediated phagocytosis of apoptotic cells
Given the close proximity of the PS- and LMIR5-binding re-
gions in TIM1, we tested whether LMIR5 interacts with TIM1 
through PS. To this end, we performed a protein–lipid overlay 
assay; although TIM1-Fc bound specifically to PS, as previously 
reported (Kobayashi et al., 2007; Miyanishi et al., 2007), we 
found no binding of LMIR5-Fc to PS or to other phospholipids 
(Fig. 3 A). Consistently, NIH3T3 cells transduced with TIM1 
Figure 2.  Ig-like domains of both LMIR5 and TIM1 are 
required for the LMIR5–TIM1 interaction. (A) Structures of 
LMIR5 extracellular domain in LMIR5-Fc and its deletion mutants. 
(B) The culture supernatants from 293T cells transduced with 
LMIR5-Fc or LMIR5-Fc mutants were immunoprecipitated (IP) 
with protein A, and then immunoblotted (IB) with anti–human 
IgG antibody. (C) TIM1-transduced Ba/F3 cells were stained with 
LMIR5-Fc or LMIR5-Fc mutants (continuous line histograms). 
Control staining with human IgG1 is shown (shaded histo-
grams). (D) Ba/F3 cells transduced with Flag-tagged TIM1, TIM1 
(WF/AA), TIM1 (ND/AA), or mock were stained with LMIR5-Fc 
(top, continuous line histograms) or anti-Flag antibody (bottom, 
continuous line histograms). Control staining with human (top, 
shaded histograms) and mouse IgG1 (bottom, shaded histo-
grams) is shown. All data shown are representative of three 
independent experiments.JEM VOL. 207, July 5, 2010 
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neutrophils  by  flow  cytometry  (Fig.  5  C). 
Semiquantitative RT-PCR analysis demon-
strated no significant difference of LMIR1–4 
transcript levels in BM cells between WT and 
LMIR5/ mice (Fig. S5 C). LMIR5/ mice 
were born at the expected Mendelian ratio and 
showed no obvious abnormalities. In addition, 
WT and LMIR5/ mice did not reveal major 
differences in the myeloid and lymphoid devel-
opment of the BM, spleen, thymus, peripheral 
blood, and peritoneal cells (Fig. S6).
To address the physiological significance of the LMIR5–
TIM1 interaction, we chose a model for kidney ischemia/ 
reperfusion injury (IRI; Kelly et al., 1996; Ichimura et al., 
1998, 2008; Wu et al., 2007; Lech et al., 2009; Waanders   
et al., 2010), which is the known in vivo model for TIM1 
induction. Consistent with previous reports (Ichimura et al., 
1998, 2008; Waanders et al., 2010), TIM1 mRNA levels   
rapidly increased at day 1 after IRI and diminished through 
days 2–4 in the IRI kidneys of WT mice, whereas they were 
maintained at low levels before and after IRI in contralateral 
kidneys (Fig. 5 A, left). TIM4 mRNA was undetectable in 
IRI  or  contralateral  kidneys  (unpublished  data).  Notably, 
LMIR5 mRNA levels increased through days 1 and 2, and 
thereafter decreased through days 3 and 4 in IRI but not 
control kidneys of WT mice (Fig. 5 A, right). Further exami-
nation showed that in IRI kidneys of WT mice, TIM1 was 
highly expressed in CD45 (nonhematopoietic) cells as com-
pared with CD45+ (hematopoietic) cells, whereas LMIR5 
was predominantly expressed in CD45+ cells (Fig. 5 B). To-
gether with previous findings (Kelly et al., 1996; Ichimura et al.,   
1998, 2008; Wu et al., 2007; Lech et al., 2009; Waanders et al., 
2010), these results indicated that LMIR5-expressing neutro-
phils were recruited in IRI kidneys after the up-regulation 
of TIM1 expression in the renal tubular cells. We then   
no detectable expression levels of TIM2 and TIM4 in mast 
cells (Fig. S4). However, TIM1 expression in mast cells 
was not confirmed in either protein or transcript levels 
(Fig. S4). Therefore, we reasoned that the involvement of 
the TIM1–TIM1/4 interaction in TIM1-Fc–induced acti-
vation of mast cells was negligible. We then performed 
co-culture of LMIR5- or mock-transduced FLMCs with   
TIM1-transduced Chinese hamster ovary (CHO) cells, demon-
strating higher levels of IL-6 released into the supernatants 
of the former co-culture as compared with the latter (Fig. 4 C, 
left). In addition, we found higher levels of IL-6 released 
into the supernatants in the co-culture of LMIR5-expressing 
FLMCs with TIM1-transduced CHO cells as compared with 
mock-transduced CHO cells (Fig. 4 C, right). These results 
indicated that interaction of LMIR5 with surface-expressed 
TIM1 as well as soluble TIM1 induced the LMIR5-mediated 
activation of mast cells.
In vivo evidence that the LMIR5–TIM1 interaction induces 
the accumulation of neutrophils
To investigate the physiological role of TIM1 as a ligand for 
LMIR5, we generated LMIR5-deficient mice (Fig. S5 A). 
We confirmed gene targeting by genomic PCR (Fig. S5 B) 
and the complete absence of LMIR5 expression in BM   
Figure 3.  LMIR5 is not involved in TIM1- or TIM4-
mediated phagocytosis of apoptotic cells through 
recognition of PS. (A) PIP strips spotted with the indi-
cated phospholipids were incubated with TIM1-Fc or 
LMIR5-Fc. (B and C) NIH3T3 cells transduced with either 
TIM1, LMIR5, or mock were co-cultured with CFSE- 
labeled live or apoptotic U937 cells in the presence (C) or 
absence (B) of the indicated antibodies or Fc fusion pro-
teins. The percentage of NIH3T3 cells containing CFSE-
labeled U937 cells was determined. (D) Peritoneal 
macrophages were co-cultured with CFSE-labeled apop-
totic thymocytes for 30 min in the presence of 10 µg/ml 
TIM1-Fc, LMIR5-Fc, or human IgG1. After removal of 
nonadherent cells, peritoneal macrophages were stained 
with PE-conjugated anti-CD11b antibody. The percentage 
of CFSE/CD11b double-positive cells was determined by 
flow cytometric analysis. (E) Based on the flow cytomet-
ric analysis in D, the percentage of phagocytosis is 
shown. All data points correspond to the means ± SD of 
triplicate samples. Data are representative of three inde-
pendent experiments. *, P < 0.05.1506 TIM1 is an endogenous ligand for LMIR5/CD300b | Yamanishi et al.
of IL-6 and MCP-1 were produced in IRI kidneys 
compared with contralateral kidneys of WT mice 
(Fig. 6 A and Fig. S7 B). Notably, LMIR5 deficiency 
attenuated the increase of cytokine production in 
IRI kidneys, whereas it did not affect TIM1 expres-
sion in IRI kidneys (Fig. 6 A and Fig. S7 B). In WT 
mice, IL-6 transcripts were equivalently expressed   
in CD45+ and CD45 cells of IRI kidneys, whereas 
MCP-1 transcripts were highly expressed in CD45+ 
cells (Fig. 6 B). These results indicated a contributory 
role of CD45+ cells in cytokine/chemokine produc-
tion of IRI kidneys. Histological analysis of IRI kid-
neys showed severe tubular damage of WT mice, as 
indicated by widespread tubular necrosis in the outer 
medulla and cast formation in the inner medulla at 1 d after IRI 
(Fig. 6 C). On the other hand, tubular damage was significantly 
ameliorated by LMIR5 deficiency (Fig. 6 C). Related to this, 
the number of neutrophils infiltrating the interstitial compart-
ments of IRI kidneys was lower in LMIR5-deficient mice com-
pared with WT mice (Fig. 6, D and E). We found no tubular 
damage as well as negligible numbers of neutrophils in contralat-
eral kidneys of WT or LMIR5/ mice (Fig. 6, C and E; and 
not depicted). Importantly, immunohistological examination 
displayed the frequent colocalization of LMIR5-expressing   
neutrophils and TIM1-expressing tubular epithelial cells in   
IRI kidneys of WT mice (Fig. 6 F). Altogether, LMIR5   
deficiency ameliorated ischemia-induced renal tubular damage 
associated with neutrophil accumulation.
DISCUSSION
Identification of ligands for immune receptors is indispens-
able  for  delineation  of  their  biological  functions.  Recent 
studies led us to postulate that paired immune receptors have 
acquired the ability to recognize both endogenous and exog-
enous ligands (Shiratori et al., 2004; Satoh et al., 2008). The 
same hypothesis could be applied to LMIR/CD300 family 
members, but their ligands remained unknown.
compared the IRI kidneys from WT mice with those from 
LMIR5/ mice. Flow cytometric analysis delineated that 
the percentage of neutrophils in IRI kidneys was lower in 
LMIR5-deficient mice compared with WT mice (Fig. 5 D). 
On the other hand, in vitro migration assays demonstrated a 
comparable ability of WT and LMIR5/ neutrophils to mi-
grate toward chemoattractants such as MIP-2, C5a, KC, and 
fMLP (Fig. S7 A). To further test if the LMIR5–TIM1 inter-
action was involved in the neutrophil accumulation in the kid-
ney IRI, we used dorsal air pouch experiments as an in vivo 
neutrophil recruitment model. Importantly, both TIM1-Fc–
induced neutrophil migration and cytokine production in 
dorsal air pouches were dampened by LMIR5 deficiency,   
although the response to LPS was comparable between both 
mice (Fig. 5, E and F). These results suggested that the 
LMIR5–TIM1 interaction contributed to the accumulation   
of neutrophils in kidney IRI.
LMIR5 deficiency ameliorates renal tubular damage induced 
by kidney IRI
Next,  we  examined  if  LMIR5  deficiency  attenuated  the   
renal damage induced by IRI. As previously reported (Kelly   
et al., 1996; Wu et al., 2007; Lech et al., 2009), higher amounts 
Figure 4.  The binding of TIM1 to LMIR5 induced 
LMIR5-mediated mast cell activation. (A) BMMCs trans-
duced with LMIR5 or mock were stimulated with anti-
LMIR5 antibody, goat IgG, or SPE-7 IgE (left), or with 
TIM1-Fc or human IgG1 (right). Cell lysates were subjected  
to immunoblotting (IB) with anti–phospho-p44/42 mitogen-
activated protein kinase (pERK1/2). One representative  
out of three independent experiments is shown. (B) Either  
WT or DAP12-deficient FLMCs transduced with LMIR5 or 
mock were stimulated with 100 nM PMA (right) or with 
TIM1-Fc, human IgG1 (hIgG1), or PBS (left). (C) FLMCs 
transduced with LMIR5 or mock were co-cultured with 
TIM1-expressing CHO cells (left), or LMIR5-expressing 
FLMCs were co-cultured with CHO cells transduced with 
TIM1 or mock for 24 h (right). IL-6 released into the culture 
supernatants was measured by ELISA. Data are means ± SD 
of four triplicate samples. One representative out of four 
independent experiments is shown. Statistically significant 
differences are shown. *, P < 0.05.JEM VOL. 207, July 5, 2010 
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that LMIR5 is not directly involved in the clearance 
of  apoptotic  cells.  Because  LMIR5  is  a  DAP12-
coupled activating receptor, it is plausible that the 
LMIR5–TIM1/4  interaction  induces  activation  of 
LMIR5-expressing mast cells. However, in in vitro 
experiments, myeloid cells were not activated by the 
interaction  of  endogenous  LMIR5  and  TIM1.  As 
one possible explanation, we assumed that biological 
events induced by the LMIR5–TIM1 interaction   
require in vivo environmental factors such as cyto-
kines/chemokines,  cell–cell  interaction,  or  cell– 
extracellular matrix interaction. We also postulated 
that the biological outcomes induced by the LMIR5–
TIM1 interaction might be evident in a pathological 
situation where soluble TIM1 and/or surface-expressed 
LMIR5 increase at high levels. To test this, we gen-
erated LMIR5-deficient mice and used a mouse model   
of acute kidney injury, IRI, where TIM1 is up-regulated 
in the IRI kidney. Intriguingly, LMIR5 deficiency attenu-
ated the acute kidney damage, characterized by tubular   
necrosis and cast formation. In addition, the recruitment of 
neutrophils in IRI kidneys, reportedly associated with tissue 
damage (Kelly et al., 1996; Wu et al., 2007; Bolisetty and 
Agarwal, 2009; Lech et al., 2009), was suppressed in LMIR5-
deficient mice. Notably, IRI induced the marked up-regulation 
of TIM1 expression in epithelial tubular cells, followed by 
the recruitment of neutrophils to IRI kidneys. Considering 
that a large amount of soluble TIM1 is released in the isch-
emic kidneys, it was possible that LMIR5-expressing my-
eloid cells interacted with soluble TIM1 or surface TIM1 in 
In the present study, we identified TIM1 and TIM4 as 
endogenous ligands for LMIR5. Because TIM1 and TIM4 
play an important role in mediating uptake of apoptotic cells 
through recognition of PS, we were curious about the spe-
cific functions of LMIR5 in a similar context. In fact, the Ig-
like domain of LMIR5 bound to TIM1 in the vicinity of the 
PS-binding site within the Ig-like domain of TIM1 (Fig. 2). 
However, the LMIR5–TIM1/4 interaction did not hamper 
the TIM1/4-mediated clearance of apoptotic cells (Fig. 3, 
C–E). One possible explanation is that TIM1 or TIM4   
binds to PS at a higher affinity in comparison to LMIR5.   
Alternatively, the binding site of TIM1 or TIM4 to LMIR5 
might be close, but not identical, to that to PS. In addition, 
several lines of evidence (Fig. 3, A and B) led us to conclude 
Figure 5.  In vivo evidence that the LMIR5–TIM1 interac-
tion induced accumulation of neutrophils. (A and B) Relative 
gene expression levels of TIM1 (left) or LMIR5 (right) in the IRI or 
contralateral (Co) kidneys from WT mice at different time intervals 
after surgery (A) or in the CD45 or CD45+ cells sorted from the 
IRI kidneys of WT mice at 24 h after surgery (B). Data are means ± 
SD (n = 6 mice in each group). Data are representative of three 
independent experiments. (C) Surface expression levels of LMIR5 
(bottom, continuous line histograms) as well as CD11b and Gr-1 
(top) were examined in BM neutrophils from WT or LMIR5/  
(KO) mice. Control staining with goat IgG is shown (shaded histo-
grams). Data are representative of five independent experiments. 
(D) Percentages of CD11b+Gr-1+ neutrophils in either contralateral 
or IRI kidney cells from WT or KO mice at 24 h after surgery (left). 
The ratio of neutrophil counts in IRI kidneys to those in contralat-
eral kidneys was determined. Data are means ± SD (n = 6 mice in 
each group; right). Two independent experiments were performed. 
(E) Either 100 µg TIM1-Fc or control Fc, or 1 mg LPS was injected 
into the air pouches of WT or LMIR5/ mice. At 4 h after injec-
tion, neutrophils recruited into the pouches were counted. Each 
symbol represents an individual mouse. The number of mice in 
each group is shown. Two independent experiments were per-
formed. (F) IL-6 released into the dorsal air pouches (ELISA). The 
number of mice in each group is shown. Two independent experi-
ments were performed. Data in D–F are means ± SD. Statistically 
significant differences are shown. *, P < 0.05.1508 TIM1 is an endogenous ligand for LMIR5/CD300b | Yamanishi et al.
promotes the neutrophil recruitment, leading to the renal tu-
bular damage. This scenario was supported by the finding 
that the neutrophil accumulation induced by TIM1-Fc, a 
mimic form of soluble TIM1, was dampened by LMIR5   
deficiency in the dorsal air pouch experiments. Because the 
migration of BM neutrophils toward chemoattractants was 
not affected by LMIR5 deficiency in the in vitro assay   
(Fig. S7 A), we reasoned that the impaired recruitment of 
neutrophils in LMIR5-deficient mice was presumably caused 
by the lack of LMIR5–TIM1 interaction, but not to the   
epithelial cells. In support of this, histological examination 
displayed the frequent colocalization of LMIR5-expressing 
neutrophils and TIM1-expressing epithelial cells in IRI kid-
neys. Taking these observations together, we assume the   
relevant mechanism to be as follows. First, soluble TIM1 re-
leased from or surface TIM1 expressed by renal tubular cells 
activates LMIR5-expressing myeloid cells, including resident 
macrophages/monocytes, mast cells, neutrophils, and den-
dritic  cells  through  the  LMIR5–TIM1  interaction.  Then, 
production of cytokines/chemokines and/or soluble TIM1 
Figure 6.  LMIR5/ mice were protected from renal IRI. (A and B) IL-6 or MCP-1 protein expression (ELISA) in contralateral (Co) or IRI kidneys from 
WT or LMIR5/ mice at 24 h after surgery or in nontreated kidneys (A), and relative gene expression levels of IL-6 or MCP-1 (real-time PCR) in CD45 or 
CD45+ cells sorted from IRI kidneys at 24 h after surgery (B). Data are means ± SD (n = 6 mice in each group). Statistically significant differences are 
shown. *, P < 0.05. Data are representative of three independent experiments. (C and D) Tubular injury (C) or neutrophil accumulation within the intersti-
tium in IRI kidneys (D) of WT and LMIR5/ mice at 24 h after surgery. Representative sections of the outer and inner medulla from contralateral or IRI 
kidneys from WT and LMIR5/ mice at 24 h after surgery. (C) Hematoxylin and eosin staining. Bars, 100 µm. Three independent experiments were per-
formed. (D) Immunohistochemical identification of neutrophils (brown) in the outer and inner medulla (top and bottom, respectively). Immunohistochem-
ical identification of neutrophils (green) in the outer medulla (middle). The nuclei were counterstained with DAPI (blue). Bars, 100 µm. Three independent 
experiments were performed. (E) Neutrophil counts of 10 high-power fields (HPFs) from each section from the outer medulla. Data shown are means ± 
SD (n = 8 mice in each group). Statistically significant differences are shown. *, P < 0.05. Three independent experiments were performed. (F) Immuno-
histochemical identification of LMIR5-expressing neutrophils (red) and TIM1-expressing epithelial cells (green) in the outer medulla of IRI kidneys of WT 
mice. The nuclei were counterstained with DAPI (blue). Bars, 10 µm. Three independent experiments were performed. ND, not detected.JEM VOL. 207, July 5, 2010 
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(provided by H. Arase, Osaka University, Osaka, Japan) from the cDNA   
library were transfected into PLAT-E packaging cells (Morita et al., 2000). 
Infected Ba/F3 cells were stained by LMIR5-Fc. After three rounds of en-
richment using a FACSAria (BD), single-cell clones were obtained. The in-
tegrated cDNA was recovered by PCR and sequenced.
PIP-strip  assay.  PIP-strip  assay  was  performed  as  previously  described   
(Kobayashi et al., 2007). PIP strips were purchased from Echelon Bioscience.
Phagocytosis assay. Phagocytosis assay was performed as previously de-
scribed (Kobayashi et al., 2007; Miyanishi et al., 2007). CFSE-labeled apop-
totic  thymocytes  were  coincubated  with  peritoneal  macrophages  in  the 
presence of 10 µg/ml of the Fc fusion proteins indicated in the figures for   
30 min. Alternatively, CFSE-labeled live or apoptotic U937 cells were co-
incubated with NIH3T3 transfectants in the presence of 20 µg/ml of the   
antibodies or Fc fusion proteins indicated in the figures for 45 min. The   
percentage of CSFE+ cells was measured by flow cytometric analysis.
Immunoprecipitation and Western blotting. Transfected Ba/F3 cells 
were incubated with 20 µg/ml LMIR5-Fc, human IgG1, anti-Flag mAb, or 
mouse IgG1. Cell lysates were immunoprecipitated by using protein A– 
sepharose.  To  detect  phosphorylation  of  ERK1/2,  transfected  BMMCs 
preincubated with 20 µg/ml TIM1-Fc or human IgG1 for 30 min on ice 
were stimulated in anti–human IgG antibody–coated plates at 37°C for   
7 min, as previously described (Kumagai et al., 2003; Izawa et al., 2007; Yamanishi   
et al., 2008).
Measurement of cytokines. For co-culture assay, 5 × 104 CHO cells 
transduced with TIM1 or mock transduced were co-cultured with 2 × 105 
FLMCs transduced with LMIR5 or mock transduced for 24 h. Concentrations 
of IL-6 in the culture supernatants and those of IL-6 and MCP-1 in the renal   
extract were measured by ELISA, as previously described (Izawa et al., 2007; Wu 
et al., 2007; Yamanishi et al., 2008). Protein levels of cytokines/chemokines in 
the renal extract were corrected for the total amounts of protein.
Neutrophil infiltration into mouse dorsal air pouch. Air pouches were 
formed on the dorsum of mice as previously described (Sin et al., 1986).   
In brief, 7 ml of sterile air was injected subcutaneously into the back of mice 
on days 0 and 3. On day 6, 100 µg TIM1-Fc or of control Fc, or 1 mg LPS 
dissolved in 1 ml of PBS was injected into the air pouches. 4 h after the in-
jection, the air pouches were lavaged. Total cells in the lavage fluid were 
counted and the percentages of Gr-1+/CD11b+ neutrophils were estimated 
by FACS analysis. IL-6 levels in the lavage fluid were measured by ELISA.
Induction of renal IRI. In brief, the left renal pedicle of male mice was 
exposed and clamped for 45 min with a microaneurysm clamp via flank inci-
sion, as previously described (Lech et al., 2009). Mice were sacrificed at 24, 
48, and 96 h after reperfusion. The IRI and contralateral kidneys were col-
lected for histological analysis, flow cytometry analysis, and measurements of 
cytokines and chemokines.
Histological analysis. Formalin-fixed kidneys were embedded in paraffin 
and stained with hematoxylin and eosin by standard methods. Neutrophils 
were detected using rat anti–mouse neutrophil mAb (clone 4/7; AbD Sero-
tec), as previously described (Wu et al., 2007). Neutrophils in the outer   
medulla were counted in 10 consecutive high-power fields (400×) from 
each section. Immunofluorescence staining was performed as previously de-
scribed (Morikawa et al., 2004). In brief, 6-µm-thick frozen sections were 
stained with primary antibodies: anti-LMIR5 antibody, anti-TIM1 (RMT1-17) 
mAb, rat anti–mouse neutrophil mAb, and the appropriate secondary antibodies 
(Jackson  ImmunoResearch  Laboratories,  Inc.).  All  sections  were  counter-
stained with DAPI (Invitrogen).
Statistical analysis. Data are shown as means ± SD. Statistical signifi-
cance was determined by the Student t test, with P < 0.05 considered sta-
tistically significant.
defective  migratory  function  of  LMIR5-deficient  neutro-
phils. Of note, neutrophils failed to migrate toward TIM-Fc 
alone in the in vitro assay (unpublished data), suggesting the 
requirement of additional signals supplied by the surrounding 
cells in vivo. We concluded that soluble TIM1 induced the 
neutrophil accumulation via LMIR5 under in vivo condi-
tions through both direct and indirect mechanisms. How-
ever, TIM1-Fc also binds to LMIR5-deficient neutrophils as 
well as parent Ba/F3 cells (Fig. S1 C and not depicted), sug-
gesting the existence of unidentified ligands for TIM1. Al-
though recent studies implied multiple mechanisms in the 
pathology of kidney IRI (Kelly et al., 1996; Wu et al., 2007; 
Bolisetty and Agarwal, 2009; Jang and Rabb, 2009; Lech et al., 
2009), the present paper shows that the LMIR5–TIM1 inter-
action was involved in the tubular damage in the acute phase 
after IRI.
In conclusion, we provide evidence that TIM1 is a physio-
logical ligand for LMIR5 and that the LMIR5–TIM1 inter-
action is pivotal in neutrophil accumulation related to tissue   
damage in kidney IRI. Blocking the LMIR5–TIM1 inter-
action might be a novel therapeutic strategy for acute renal 
tubular damage.
MATERIALS AND METHODS
Cells and mice. DAP12/ mice were used as previously described (Kaifu 
et al., 2003). Animal experiments were conducted in accordance with the 
guidelines of and with permission provided by the Animal Care and Use 
Committee of the University of Tokyo (approval no. 20-8). LMIR5/ 
mice were generated as previously described (Murata et al., 2004). We used 
LMIR5/ mice that had been backcrossed for at least eight generations with 
C57BL/6 mice (Charles River).
BM-derived cells, FLMCs, and peritoneal macrophages were generated 
as previously described (Izawa et al., 2007; Kobayashi et al., 2007; Miyanishi 
et al., 2007; Yamanishi et al., 2008). Single-cell suspensions of kidney cells 
were obtained by using Liberase Research Grade Enzyme (Roche).
Antibodies and other reagents. Anti-LMIR5 polyclonal antibody and 
anti-TIM1 mAb (222414) were obtained from R&D Systems. Biotinylated 
anti–mouse  TIM1  (RMT1-10  or  RMT1-4)  mAbs  were  obtained  from 
eBioscience. Anti–mouse TIM1 (RMT1-17), TIM2 (RMT2-14), TIM3 
(RMT3-23), and TIM4 (RMT4-54) mAbs have been previously described 
(Nakayama et al., 2009).
Gene expression analysis. Real-time PCR or RT-PCR was performed 
using gene-specific primers (Table S1) as previously described (Yamanishi   
et al., 2008).
Generation of Fc fusion proteins. The cDNA fragments corresponding 
to the extracellular domains of mouse LMIR1/2/3/4/5, LMIR5 deletion 
mutants, TIM1, or TIM4 were used. The Fc fusion proteins were purified 
as previously described (Satoh et al., 2008).
Flow cytometry. In some experiments, cells were stained with 1 µg/ml of 
Fc fusion proteins or human IgG1 followed by 10 µg/ml of PE-conjugated 
F(ab)2 donkey anti–human IgG. Flow cytometric analysis was performed 
with a FACSCalibur (BD) equipped with CellQuest software (BD) and 
FlowJo software (Tree Star, Inc.), as previously described (Izawa et al., 2007; 
Yamanishi et al., 2008).
Retrovirus-mediated expression cloning. Expression cloning was per-
formed as previously described (Kitamura et al., 2003). In brief, plasmids 1510 TIM1 is an endogenous ligand for LMIR5/CD300b | Yamanishi et al.
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